Skip to main content
. 2016 Jun 8;11(7):1163–1172. doi: 10.2215/CJN.10441015

Table 4.

All–cause mortality risk

Variables Hazard Ratio (95% CI) P Value
Age, >58 versus ≤58 yr 1.58 (1.10 to 2.28) 0.01
Sex, men versus women 1.07 (0.73 to 1.56) 0.53
Diabetes mellitus, present versus absent 1.56 (1.07 to 2.26) 0.01
Smoking, yes versus no 1.10 (0.75 to 1.61) 0.47
SGA, malnourished versus well nourished 2.28 (1.56 to 3.33) <0.001
eGFR, ≤6.9 versus >6.9 ml/min per 1.73 m2 1.42 (0.99 to 2.04) 0.09
Calendar year period, 2010–2014 versus 2006–2009 1.21 (0.62 to 2.37) 0.66
Calendar year period, 2010–2014 versus 2000–2005 0.83 (0.42 to 1.65) 0.64
Calendar year period, 2010–2014 versus 1994–1999 0.75 (0.37 to 1.56) 0.58
WBC, >8.0×103 versus ≤8.0×103/μl 1.94 (1.34 to 2.82) <0.001
IL-6, >6.7 versus ≤6.7 pg/ml 1.79 (1.20 to 2.67) 0.01
Troponin T, >0.06 versus ≤0.06 μg/L 1.49 (1.03 to 2.16) 0.14
hsCRP, >6.4 versus ≤6.4 mg/L 1.25 (0.80 to 1.95) 0.42
PLT, >261×103 versus ≤261×103/μl 1.22 (0.85 to 1.75) 0.30
sVCAM-1, >1356 versus ≤1356 ng/ml 1.15 (0.78 to 1.69) 0.43
sICAM-1, >249 versus ≤249 ng/ml 1.07 (0.76 to 1.49) 0.06
Albumin, >3.3 versus ≤3.3 g/dl 1.07 (0.75 to 1.55) 0.59
Ferritin, >122 versus ≤122 ng/ml 0.96 (0.69 to 1.34) 0.77
IGF-1, >155 versus ≤155 μg/ml 0.78 (0.54 to 1.14) 0.27
TNF, >12.1 versus ≤12.1 pg/ml 0.65 (0.44 to 0.97) 0.04
Orosomucoid, >1.1 versus ≤1.1 g/L 0.62 (0.41 to 0.95) 0.07

The output from an imputed multivariate generalized linear model (GENMOD) of all–cause mortality hazard ratios (95% CIs) estimated during 60 months of follow-up calculated for each evaluated biomarker and adjusted for other variables. Patient outcomes were censored for renal transplantation. 95% CI, 95% confidence interval; SGA, subjective global assessment of nutritional status; WBC, white blood cell; hsCRP, high–sensitivity C–reactive protein; PLT, platelet count; sVCAM-1, soluble vascular cellular adhesion molecule 1; sICAM-1, soluble intracellular adhesion molecule.